Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2.

Literature DB >> 34468703

Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2.

Shirley Shapiro Ben David¹, Israel Potasman², Daniella Rahamim-Cohen¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 34468703 PMCID： PMC8411356 DOI： 10.1001/jamaneurol.2021.3287

Source DB: PubMed Journal: JAMA Neurol ISSN： 2168-6149 Impact factor: 29.907

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

1. Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.

Authors: Arina A Tamborska; Bhagteshwar Singh; Sonja E Leonhard; Eva Maria Hodel; Julia Stowe; Taylor Watson-Fargie; Peter M Fernandes; Andreas C Themistocleous; Jacob Roelofs; Kathryn Brennan; Caroline Morrice; Benedict D Michael; Bart C Jacobs; Helen McDonald; Tom Solomon
Journal: BMJ Neurol Open Date: 2022-07-12

Review 2. COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Authors: Naim Mahroum; Noy Lavine; Aviran Ohayon; Ravend Seida; Abdulkarim Alwani; Mahmoud Alrais; Magdi Zoubi; Nicola Luigi Bragazzi
Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786

Review 3. What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions.

Authors: Toru Awaya; Masao Moroi; Yoshinari Enomoto; Taeko Kunimasa; Masato Nakamura
Journal: Vaccines (Basel) Date: 2022-05-28

4. Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based Study.

Authors: Oren Tomkins-Netzer; Shaul Sar; Ofra Barnett-Griness; Binyamin Friedman; Hana Shyriaieva; Walid Saliba
Journal: Ophthalmology Date: 2022-05-25 Impact factor: 14.277

Review 5. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.

Authors: Arens Taga; Giuseppe Lauria
Journal: J Peripher Nerv Syst Date: 2022-03-14 Impact factor: 5.188

6. Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination.

Authors: Aleksandra Murawska Baptista; Akankcha Alok; Claudia Libertin
Journal: IDCases Date: 2022-03-05

Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2.

1. Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.

Review 2. COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Review 3. What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions.

4. Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based Study.

Review 5. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.

6. Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination.

7. Patients' attitude towards vaccination after Guillain Barré syndrome.

8. Rare occurrence of Guillain-Barré syndrome after Moderna vaccine.

9. Guillain-Barré syndrome after mRNA-1273 (Moderna) COVID-19 vaccination: A case report.

Review 10. COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series.